SCHEMBL14959162

SCHEMBL14959162

COc1ccc([N+](=O)[O-])cc1/C=N\NC(=O)CNc1cc(Br)c(C)c(Br)c1

nearest known ligand 0.78

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LIG1 P18858 2/20 0.78
LIG3 P49916 1/20 0.78
ALDH1A1 P00352 8/20 0.61
MAPT P10636 11/20 0.60
KDM4E B2RXH2 5/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
HPGD P15428 1/20 0.58
KMT2A Q03164 6/20 0.55
MEN1 O00255 5/20 0.55
TDP1 Q9NUW8 3/20 0.55
POLB P06746 2/20 0.55
CYP2D6 P10635 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
RECQL P46063 1/20 0.47
SAE1 Q9UBE0 1/20 0.47
UBA2 Q9UBT2 1/20 0.47
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13401789 0.87 LIG1 (1.00) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19298155 0.87 LIG1 (1.00) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL19334306 0.79 LIG1 (0.83) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13401791 0.77 MAPT (0.64) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13401792 0.75 KDM4E (0.63) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL13673619 0.74 ALDH1A1 (0.62) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL13673617 0.74 ALDH1A1 (0.62) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL13401821 0.74 LIG1 (0.75) LIG1LIG3ALDH1A1MAPTKDM4E
SCHEMBL7748695 0.73 ALDH1A1 (0.63) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD
SCHEMBL7748699 0.73 ALDH1A1 (0.63) ALDH1A1MAPTKDM4ESMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8445537-B2 Compounds that inhibit human DNA ligases and methods of treating cancer STC.UNM (US) 2013-05-21 US disclosed